Charleston Laboratories, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2007-01-01
- Employees
- 11
- Market Cap
- -
A Study to Assess the Efficacy and Safety of Oral CL-H1T in the Treatment of Acute Migraine Pain
Phase 2
Completed
- Conditions
- PainVomitingMigraineNauseaAura
- Interventions
- Other: Placebo
- First Posted Date
- 2019-03-18
- Last Posted Date
- 2019-11-01
- Lead Sponsor
- Charleston Laboratories, Inc
- Target Recruit Count
- 475
- Registration Number
- NCT03877718
- Locations
- 🇺🇸
Suncoast Clinical Research, Inc., New Port Richey, Florida, United States
🇺🇸Mountain View Cl inical Research, Inc., Greer, South Carolina, United States
🇺🇸Harmony Clinical Research, Inc., North Miami Beach, Florida, United States
A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg for Acute Pain and the Prevention of OINV
- First Posted Date
- 2018-09-05
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Charleston Laboratories, Inc
- Target Recruit Count
- 349
- Registration Number
- NCT03657810
- Locations
- 🇺🇸
Chesapeake, Pasadena, Maryland, United States
🇺🇸Arizona Research Center, Phoenix, Arizona, United States
🇺🇸Optimal Research, Austin, Texas, United States
A Study in Opioid-Experienced, Non-Dependent Recreational Drug Users to Determine the Abuse Potential and Safety of CL-108 Tablets Administered Via the Oral Route
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2019-10-14
- Lead Sponsor
- Charleston Laboratories, Inc
- Target Recruit Count
- 40
- Registration Number
- NCT02712554
A Four-Period, Four-Treatment, Four-Way Relative Bioavailability Study of CL-108 Under Fed and Fasted Conditions
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2015-06-09
- Last Posted Date
- 2017-05-02
- Lead Sponsor
- Charleston Laboratories, Inc
- Target Recruit Count
- 20
- Registration Number
- NCT02465866
A Multi-Center Actual-Use Study on the Safety of CL 108 for the Treatment of Moderate to Severe Acute Pain Associated With Osteoarthritis of the Knee or Hip
- First Posted Date
- 2015-06-04
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Charleston Laboratories, Inc
- Target Recruit Count
- 178
- Registration Number
- NCT02462850
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
Phase III Study of the Safety and Efficacy of Cl-108 in the Treatment of Moderate to Severe Pain
Phase 3
Completed
- Conditions
- NauseaPainVomiting
- Interventions
- First Posted Date
- 2013-01-31
- Last Posted Date
- 2016-11-03
- Lead Sponsor
- Charleston Laboratories, Inc
- Target Recruit Count
- 460
- Registration Number
- NCT01780428
- Locations
- 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States
© Copyright 2025. All Rights Reserved by MedPath